ID
18587
Description
A Randomized, Open-Label Study to Compare the Efficacy and Safety of AT1001 and Enzyme Replacement Therapy (ERT) in Patients With Fabry Disease and AT1001-Responsive GLA Mutations, Who Were Previously Treated With ERT System Enrollment
Keywords
Versions (2)
- 11/2/16 11/2/16 -
- 11/11/16 11/11/16 -
Uploaded on
November 11, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
System Enrollment Galafold (migalastat) AT1001-012 NCT01218659
System Enrollment Galafold (migalastat) AT1001-012 NCT01218659
- StudyEvent: ODM
Similar models
System Enrollment Galafold (migalastat) AT1001-012 NCT01218659
- StudyEvent: ODM